Subsequent Events |
12 Months Ended | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Subsequent Events | |||||||||||||||||||||||||||||||||||||
| Subsequent Events | Note 17. Subsequent Events Unregistered sales of equity securities In connection with the Company’s continuous private offering, on January 1, 2026, February 1, 2026 and March 1, 2026, the Company sold an aggregate of 988,291, 1,140,622 and 1,796,298, respectively, of its common shares at the most recently determined net asset value per share for aggregate consideration of approximately $19,786, $22,838, and $35,964, respectively. The offer and sale of the common shares was exempt from the registration provisions of the Securities Act by virtue of Section 4(a)(2) and Rule 506 of Regulation D promulgated thereunder. The following table details the Shares sold:
|
||||||||||||||||||||||||||||||||||||